BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 9005168)

  • 21. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison between the hemodynamic effects of nitroglycerine ointment and oral isosorbide dinitrate in the treatment of left ventricular failure (author's transl)].
    Mauri F; Mafrici A; Azzollini M; Maggiulli G; Domenichini R
    G Ital Cardiol; 1981; 11(12):2070-80. PubMed ID: 6809518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P; Zieliński T; Korewicki J
    Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
    Stangl K; Baumann G; Gerzer R; Weil J
    Eur Heart J; 1991 Aug; 12(8):917-23. PubMed ID: 1655438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dobutamine and enoximone on transmitral and pulmonary venous flow characteristics in patients with left ventricular dysfunction after coronary artery bypass grafting.
    Vroom MB; van Wezel HB; vd Brink RB; vd Lee R; Eijsman L; Visser CA; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):756-63. PubMed ID: 8910155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation.
    Kirchhoff WCh; Gradaus R; Stypmann J; Deng MC; Tian TD; Scheld HH; Breithardt G; Brisse B
    J Heart Lung Transplant; 2004 Mar; 23(3):284-8. PubMed ID: 15019637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular stroke work reserve as prognostic marker in severe heart failure.
    La Vecchia L; Varotto L; Spadaro GL; Zanolla L; Fontanelli A
    Minerva Cardioangiol; 2006 Apr; 54(2):249-55. PubMed ID: 16778756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.